z-logo
open-access-imgOpen Access
Dexamethasone pulse therapy in patients of systemic sclerosis: Is it a viable proposition? A study from kashmir
Author(s) -
Farah Sameem,
Iffat Hassan,
Qazi Masood Ahmad,
Dilshad Khan,
Imran Majeed,
MA Kamili,
P Shah
Publication year - 2010
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/0019-5154.74543
Subject(s) - medicine , dexamethasone , dysphagia , systemic therapy , disease , surgery , cancer , breast cancer
Systemic sclerosis is a multisystemic autoimmune disorder. Intravenous dexamethasone pulse therapy has been used since 1998.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here